{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:10:48Z","timestamp":1792858248969,"version":"4.5.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:sec id=\"ab-eoi230060-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The identification of patients at risk of progressing from intermediate age-related macular degeneration (iAMD) to geographic atrophy (GA) is essential for clinical trials aimed at preventing disease progression. DeepGAze is a fully automated and accurate convolutional neural network\u2013based deep learning algorithm for predicting progression from iAMD to GA within 1 year from spectral-domain optical coherence tomography (SD-OCT) scans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi230060-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop a deep-learning algorithm based on volumetric SD-OCT scans to predict the progression from iAMD to GA during the year following the scan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi230060-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective cohort study included participants with iAMD at baseline and who either progressed or did not progress to GA within the subsequent 13 months. Participants were included from centers in 4 US states. Data set 1 included patients from the Age-Related Eye Disease Study 2 AREDS2 (Ancillary Spectral-Domain Optical Coherence Tomography) A2A study (July 2008 to August 2015). Data sets 2 and 3 included patients with imaging taken in routine clinical care at a tertiary referral center and associated satellites between January 2013 and January 2023. The stored imaging data were retrieved for the purpose of this study from July 1, 2022, to February 1, 2023. Data were analyzed from May 2021 to July 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi230060-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>A position-aware convolutional neural network with proactive pseudointervention was trained and cross-validated on Bioptigen SD-OCT volumes (data set 1) and validated on 2 external data sets comprising Heidelberg Spectralis SD-OCT scans (data sets 2 and 3).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi230060-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Prediction of progression to GA within 13 months was evaluated with area under the receiver-operator characteristic curves (AUROC) as well as area under the precision-recall curve (AUPRC), sensitivity, specificity, positive predictive value, negative predictive value, and accuracy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi230060-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included a total of 417 patients: 316 in data set 1 (mean [SD] age, 74 [8]; 185 [59%] female), 53 in data set 2, (mean [SD] age, 83 [8]; 32 [60%] female), and 48 in data set 3 (mean [SD] age, 81 [8]; 32 [67%] female). The AUROC for prediction of progression from iAMD to GA within 1 year was 0.94 (95% CI, 0.92-0.95; AUPRC, 0.90 [95% CI, 0.85-0.95]; sensitivity, 0.88 [95% CI, 0.84-0.92]; specificity, 0.90 [95% CI, 0.87-0.92]) for data set 1. The addition of expert-annotated SD-OCT features to the model resulted in no improvement compared to the fully autonomous model (AUROC, 0.95; 95% CI, 0.92-0.95;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.19). On an independent validation data set (data set 2), the model predicted progression to GA with an AUROC of 0.94 (95% CI, 0.91-0.96; AUPRC, 0.92 [0.89-0.94]; sensitivity, 0.91 [95% CI, 0.74-0.98]; specificity, 0.80 [95% CI, 0.63-0.91]). At a high-specificity operating point, simulated clinical trial recruitment was enriched for patients progressing to GA within 1 year by 8.3- to 20.7-fold (data sets 2 and 3).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi230060-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The fully automated, position-aware deep-learning algorithm assessed in this study successfully predicted progression from iAMD to GA over a clinically meaningful time frame. The ability to predict imminent GA progression could facilitate clinical trials aimed at preventing the condition and could guide clinical decision-making regarding screening frequency or treatment initiation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2023.4659","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T11:04:50Z","timestamp":1697713490000},"page":"1052","source":"Crossref","is-referenced-by-count":25,"title":["A Deep-Learning Algorithm to Predict Short-Term Progression to Geographic Atrophy on Spectral-Domain Optical Coherence Tomography"],"prefix":"10.1001","volume":"141","author":[{"given":"Eliot R.","family":"Dow","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Ki","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella Arnon","family":"Katz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Toth","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Electrical and Computer Engineering, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Allingham","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majda","family":"Hadziahmetovic","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyatham S.","family":"Mettu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Schuman","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Carin","sequence":"additional","affiliation":[{"name":"Department of Electrical and Computer Engineering, Duke University, Durham, North Carolina"},{"name":"King Abdullah University of Science and Technology, Thuwal, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearse A.","family":"Keane","sequence":"additional","affiliation":[{"name":"University College London Institute of Ophthalmology, National Institute for Health and Care Research, Biomedical Research Centre, Moorfields Eye Hospital National Health Services Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Henao","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina"},{"name":"Department of Electrical and Computer Engineering, Duke University, Durham, North Carolina"},{"name":"King Abdullah University of Science and Technology, Thuwal, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora M.","family":"Lad","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"eoi230060r1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/eye.1988.106","article-title":"Evolution of geographic atrophy of the retinal pigment epithelium.","volume":"2","author":"Sarks","year":"1988","journal-title":"Eye (Lond)"},{"issue":"5","key":"eoi230060r2","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.ophtha.2013.11.023","article-title":"Geographic atrophy: clinical features and potential therapeutic approaches.","volume":"121","author":"Holz","year":"2014","journal-title":"Ophthalmology"},{"issue":"9","key":"eoi230060r3","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1001\/archophthalmol.2009.198","article-title":"Change in area of geographic atrophy in the Age-Related Eye Disease study: AREDS report number 26.","volume":"127","author":"Lindblad","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"eoi230060r4","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"1","key":"eoi230060r5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ajo.2015.04.003","article-title":"Incidence of late-stage age-related macular degeneration in American Whites: systematic review and meta-analysis.","volume":"160","author":"Rudnicka","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"eoi230060r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2022.100160","article-title":"Machine learning OCT predictors of progression from intermediate age-related macular degeneration to geographic atrophy and vision loss.","volume":"2","author":"Lad","year":"2022","journal-title":"Ophthalmol Sci"},{"issue":"17","key":"eoi230060r7","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.3390\/jcm11175110","article-title":"Risk factors for progression of age-related macular degeneration: population-based amish eye study.","volume":"11","author":"Nittala","year":"2022","journal-title":"J Clin Med"},{"issue":"6","key":"eoi230060r8","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.oret.2019.12.011","article-title":"Prospective longitudinal evaluation of nascent geographic atrophy in age-related macular degeneration.","volume":"4","author":"Wu","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"eoi230060r9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ophtha.2012.07.004","article-title":"Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration.","volume":"120","author":"Leuschen","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"eoi230060r10","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1167\/iovs.12-9813","article-title":"Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD.","volume":"53","author":"Folgar","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"eoi230060r11","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.ophtha.2016.08.047","article-title":"Optical coherence tomography reflective drusen substructures predict progression to geographic atrophy in age-related macular degeneration.","volume":"123","author":"Veerappan","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi230060r12","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.ophtha.2017.06.032","article-title":"Optical coherence tomography predictors of risk for progression to non-neovascular atrophic age-related macular degeneration.","volume":"124","author":"Sleiman","year":"2017","journal-title":"Ophthalmology"},{"issue":"9652","key":"eoi230060r13","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(08)61759-6","article-title":"Age-related macular degeneration.","volume":"372","author":"Coleman","year":"2008","journal-title":"Lancet"},{"issue":"11","key":"eoi230060r14","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1001\/archopht.123.11.1570","article-title":"A simplified severity scale for age-related macular degeneration: AREDS report no. 18.","volume":"123","author":"Ferris","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"eoi230060r15","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1001\/archopht.123.11.1484","article-title":"The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17.","volume":"123","author":"Davis","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"eoi230060r16","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1167\/iovs.10-7021","article-title":"Fundus autofluorescence and spectral-domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophy.","volume":"52","author":"Fleckenstein","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi230060r19","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.cell.2018.02.010","article-title":"Identifying medical diagnoses and treatable diseases by image-based deep learning.","volume":"172","author":"Kermany","year":"2018","journal-title":"Cell"},{"issue":"23","key":"eoi230060r22","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/sim.5328","article-title":"Misuse of DeLong test to compare AUCs for nested models.","volume":"31","author":"Demler","year":"2012","journal-title":"Stat Med"},{"issue":"1","key":"eoi230060r23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests.","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"issue":"5","key":"eoi230060r24","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ophtha.2012.10.018","article-title":"Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci.","volume":"120","author":"Christenbury","year":"2013","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi230060r25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ophtha.2013.07.013","article-title":"Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography.","volume":"121","author":"Farsiu","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi230060r26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ophtha.2015.09.016","article-title":"Drusen volume and retinal pigment epithelium abnormal thinning volume predict 2-year progression of age-related macular degeneration.","volume":"123","author":"Folgar","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi230060r27","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamaophthalmol.2018.4118","article-title":"Use of deep learning for detailed severity characterization and estimation of 5-year risk among patients with age-related macular degeneration.","volume":"136","author":"Burlina","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"eoi230060r28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/tvst.9.2.25","article-title":"Artificial intelligence to stratify severity of age-related macular degeneration (AMD) and predict risk of progression to late AMD.","volume":"9","author":"Bhuiyan","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"eoi230060r29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s42256-020-0154-9","article-title":"Deep-learning-based prediction of late age-related macular degeneration progression.","volume":"2","author":"Yan","year":"2020","journal-title":"Nat Mach Intell"},{"issue":"8","key":"eoi230060r30","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1167\/iovs.18-24106","article-title":"Prediction of individual disease conversion in early AMD using artificial intelligence.","volume":"59","author":"Schmidt-Erfurth","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi230060r31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.oret.2022.08.016","article-title":"Automated identification of incomplete and complete retinal epithelial pigment and outer retinal atrophy using machine learning.","volume":"7","author":"Chiang","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"2","key":"eoi230060r32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ophtha.2022.09.004","article-title":"Incomplete retinal pigment epithelial and outer retinal atrophy: longitudinal evaluation in age-related macular degeneration.","volume":"130","author":"Wu","year":"2023","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi230060r33","doi-asserted-by":"crossref","first-page":"e665","DOI":"10.1016\/S2589-7500(21)00134-5","article-title":"Clinically relevant deep learning for detection and quantification of geographic atrophy from optical coherence tomography: a model development and external validation study.","volume":"3","author":"Zhang","year":"2021","journal-title":"Lancet Digit Health"},{"issue":"5","key":"eoi230060r34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcjo.2021.01.005","article-title":"Natural history of incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration.","volume":"56","author":"Corradetti","year":"2021","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"eoi230060r35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.oret.2021.03.008","article-title":"OCT signs of early atrophy in age-related macular degeneration: interreader agreement: classification of Atrophy Meetings report 6.","volume":"6","author":"Wu","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"eoi230060r36","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s41433-022-02097-0","article-title":"Developing and validating a multivariable prediction model which predicts progression of intermediate to late age-related macular degeneration-the PINNACLE trial protocol.","volume":"37","author":"Sutton","year":"2023","journal-title":"Eye (Lond)"},{"issue":"12","key":"eoi230060r37","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.ophtha.2014.06.034","article-title":"Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration.","volume":"121","author":"Wu","year":"2014","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi230060r38","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1097\/IAE.0000000000001283","article-title":"Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration.","volume":"36","author":"Sadda","year":"2016","journal-title":"Retina"},{"issue":"4","key":"eoi230060r39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ophtha.2016.12.002","article-title":"Imaging protocols in clinical studies in advanced age-related macular degeneration: recommendations from Classification of Atrophy Consensus meetings.","volume":"124","author":"Holz","year":"2017","journal-title":"Ophthalmology"},{"issue":"4","key":"eoi230060r40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: Classification of Atrophy report 3.","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"eoi230060r17","author":"Szegedy","year":"2015"},{"key":"eoi230060r18","author":"Sun","year":"2017"},{"key":"eoi230060r21","author":"Kingma","year":"2015"},{"key":"eoi230060r20","unstructured":"Wang? D, Yang? Y, Tao? C, . Proactive Pseudo-intervention: causally informed contrastive learning for interpretable vision models.? arxiv. Published online December 6, 2020. https:\/\/arxiv.org\/abs\/2012.03369v2"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2810428\/jamaophthalmology_dow_2023_oi_230060_1699486093.16404.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T11:02:15Z","timestamp":1700132535000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2810428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.4659","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}